2021-01-11,DiaMedica Therapeutics to Present at the H.C. Wainwright BioConnect Conference
2021-01-09,Here's Why We're Not At All Concerned With DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation
2020-12-15,DiaMedica Therapeutics Announces Enrollment of Last Patient in Diabetic Kidney Disease Cohort of Phase 2 REDUX CKD Study
2020-12-10,Is DMAC A Good Stock To Buy Now?
2020-12-10,DiaMedica Therapeutics Announces Successful Type B Meeting with FDA for the Study of DM199 in Patients with Acute Ischemic Stroke
2020-11-24,Billionaire Steven Cohen Pulls the Trigger on These 2 Penny Stocks
2020-11-19,DiaMedica Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
2020-11-11,DiaMedica Therapeutics to Participate in 11th Annual Craig-Hallum Alpha Select Conference
2020-11-10,Insider Buys DiaMedica Therapeutics Stock
2020-11-05,"DiaMedica Therapeutics, Inc. to Host Earnings Call"
2020-11-04,DiaMedica Provides a Business Update and Third Quarter 2020 Financial Results
2020-10-28,"DiaMedica Therapeutics to Report Third Quarter 2020 Financial Results and Provide a Business Update November 5, 2020"
2020-10-01,3 Strong Buy Healthcare Stocks Under $5 That Could Go Boom
2020-09-15,"DiaMedica Therapeutics to Present at Lake Streets Virtual 4th Annual (BIG4) Conference September 17, 2020"
2020-09-14,DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study
2020-08-11,DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results
2020-08-10,DiaMedica Announces Closing of $23 Million Public Offering of Common Shares
2020-08-06,"DiaMedica Therapeutics to Report Second Quarter 2020 Financials and Provide a Business Update August 12, 2020"
2020-08-06,DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares
2020-08-05,DiaMedica Announces Proposed Public Offering of Common Shares
2020-06-10,Hedge Funds Getting Interested In DiaMedica Therapeutics Inc. (DMAC)
2020-05-19,"DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020"
2020-05-13,DiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke Study
2020-05-13,DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
2020-05-07,"DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020"
2020-03-26,DiaMedica Therapeutics to Present Research at National Kidney Foundation 2020 Spring Clinical Meetings Live Virtual Conference
2020-03-24,"DiaMedica Therapeutics, Inc. to Host Earnings Call"
2020-03-23,DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update
2020-03-22,"The Week Ahead In Biotech: Bristol-Myers, Rockwell Medical Await FDA Decisions, COVID-19 Updates In Focus"
2020-03-17,"DiaMedica Therapeutics to Report Fourth Quarter 2019 Financials and Provide a Business Update March 24, 2020"
2020-03-09,"DiaMedica Therapeutics to Participate at 32nd Annual ROTH Conference on March 15-17, 2020"
2020-02-13,DiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common Shares
2020-02-11,DiaMedica Announces Pricing of Public Offering of Common Shares
2019-12-23,Hedge Funds Have Never Been More Bullish On DiaMedica Therapeutics Inc. (DMAC)
2019-12-17,DiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney Disease
2019-11-13,DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update
2019-11-06,"DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019"
2019-11-05,DiaMedica Therapeutics to Participate in 10th Annual Craig-Hallum Alpha Select Conference
2019-10-14,DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease
2019-09-06,"DiaMedica Therapeutics to Present at Lake Streets 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019"
2019-09-03,DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor Conference
2019-08-13,DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
2019-08-12,"DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019"
2019-08-08,"DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August 13, 2019"
2019-06-21,"The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy"
2019-06-20,"The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge"
2019-06-19,DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants
2019-05-21,DiaMedica Therapeutics Announces Formation of Scientific Advisory Board for Kidney Disease
2019-05-14,"DiaMedica Therapeutics, Inc. to Host Earnings Call"
2019-05-13,DiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Update
2019-05-06,"DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development Programs on May 14, 2019"
2019-04-30,DiaMedica Therapeutics to Present at CKD3 Kidney Summit Meeting
2019-03-19,DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update
2019-03-18,DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call
2019-03-12,"DiaMedica Therapeutics to Attend 31st Annual ROTH Investor Conference on March 18-19, 2019"
2019-02-14,DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney Disease
2019-01-22,"DiaMedica Therapeutics Announces Publication of a Paper, Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke, in the Journal Therapeutic Advances in Neurological Disorders"
2019-01-16,OTC Markets Group Announces Quarterly Index Performance and Rebalancing
2019-01-10,"The Daily Biotech Pulse: Cancer Genetics Prices Offering, DiaMedica Delists From Canadian Exchange, Medigus CEO Quits"
2019-01-09,DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture Exchange
2019-01-03,UPDATE - DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease
2018-12-02,"IPO Outlook For The Week: Proteins, Fashion And Finance"
